Project information
Evaluation of dentritic cells administration in multiple myeloma.
- Project Identification
- NC6152
- Project Period
- 1/2000 - 1/2002
- Investor / Pogramme / Project type
-
Ministry of Health of the CR
- R&D of Oncology
- MU Faculty or unit
- Faculty of Medicine
Due to the short event-free survival and poor prognosis of patients in relapsing MM despite the use of myeloablative therapy we will try to improve their prognosis by using administration of dendritic cells primed with specific antigen. Idiotypic protein or peptides from myeloma cells lysate will be used as tumor associated antigens.
Publications
Total number of publications: 2
2003
-
Generation of antigen-loaded dendritic cells in a serum-free medium using different cytokine combinations.
Vaccine, year: 2003, volume: neuveden, edition: 2/2003
2000
-
Dendritic Cell Biology anf the Application of Dendritic Cells to Imunotherapy of Multiple Myeloma
Medical Oncology, year: 2000, volume: 2000, edition: 17